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Deficiency of the Mitochondrial Electron Transport Chain
in Muscle Does Not Cause Insulin Resistance
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Abstract
Background: It has been proposed that muscle insulin resistance in type 2 diabetes is due to a selective decrease in the
components of the mitochondrial electron transport chain and results from accumulation of toxic products of incomplete
fat oxidation. The purpose of the present study was to test this hypothesis.
Methodology/Principal Findings: Rats were made severely iron deficient, by means of an iron-deficient diet. Iron
deficiency results in decreases of the iron containing mitochondrial respiratory chain proteins without affecting the
enzymes of the fatty acid oxidation pathway. Insulin resistance was induced by feeding iron-deficient and control rats a
high fat diet. Skeletal muscle insulin resistance was evaluated by measuring glucose transport activity in soleus muscle
strips. Mitochondrial proteins were measured by Western blot. Iron deficiency resulted in a decrease in expression of
iron containing proteins of the mitochondrial respiratory chain in muscle. Citrate synthase, a non-iron containing
citrate cycle enzyme, and long chain acyl-CoA dehydrogenase (LCAD), used as a marker for the fatty acid oxidation
pathway, were unaffected by the iron deficiency. Oleate oxidation by muscle homogenates was increased by high fat
feeding and decreased by iron deficiency despite high fat feeding. The high fat diet caused severe insulin resistance of
muscle glucose transport. Iron deficiency completely protected against the high fat diet-induced muscle insulin
resistance.
Conclusions/Significance: The results of the study argue against the hypothesis that a deficiency of the electron transport
chain (ETC), and imbalance between the ETC and b-oxidation pathways, causes muscle insulin resistance.
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proposed that, because of this discrepancy, toxic products of
incomplete fatty acid oxidation accumulate and mediate skeletal
muscle insulin resistance [12].
The purpose of the present study was to test this hypothesis. For
the experimental model, we used rats made severely iron deficient.
Iron deficiency results in a decrease in the iron-containing
constituents of the mitochondrial respiratory chain without
affecting the enzymes of the fatty acid oxidation pathway [13].
As a model of skeletal muscle insulin resistance we used rats fed a
high fat diet, which rapidly develop what appears to be the rodent
equivalent of the visceral obesity/metabolic/insulin-resistance
syndrome [14–17].
Iron deficiency could have effects on the liver, pancreatic beta
cells, adipose tissue and brain that might affect insulin production,
whole body insulin action and glucose uptake and metabolism.
Such effects may be interesting, but have no direct relevance to the
hypothesis being evaluated in this study, which involves only
skeletal muscle. This study, therefore, deals only with the effect of
an imbalance between the mitochondrial fatty acid oxidation
pathway and the capacity of the electron transport chain on
insulin-stimulated glucose transport in skeletal muscle.

Introduction
There has been much interest in the possibility that the insulin
resistance in obese individuals and patients with type 2 diabetes is
mediated by mitochondrial deficiency in skeletal muscle [1–10].
This possibility was suggested by the finding that obese insulin
resistant individuals and type 2 diabetics generally have about
30% less mitochondria in their skeletal muscles than age-matched
individuals with normal insulin action [1–7]. The mechanism by
which ‘‘mitochondrial deficiency’’ is thought to cause insulin
resistance is accumulation of intramuscular lipids as a result of a
decreased capacity for fat oxidation [2,9]. There are a number of
reasons why this hypothesis is unlikely to be correct, including
the fact that diabetic muscle can increase fat oxidation many-fold
in response to exercise, indicating that a 30% decrease in mitochondria is not limiting for fat oxidation at rest [11]. However,
Ritov et al. [12] have proposed the new concept that insulin
resistance is not due to a decrease in skeletal muscle mitochondria
per se but to a selective decrease in the components of the
mitochondrial electron transport chain, with no decrease in the
enzymes of the mitochondrial fatty acid oxidation pathway. They
PLoS ONE | www.plosone.org
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Table 1. Body weights and glucose and insulin levels.

Diets
Low Fat Normal Iron

Low Fat Iron Deficient

High Fat Normal Iron

High Fat Iron Deficient

Body Weights, g n = 11

44065

42669

477611*

465616*

Glucose mg/dl n = 10

12063

13263

13967

140613

Insulin, mU/ml n = 6

21.360.8

{

---

6966.2

34.462.5

Values are means 6 SE. n = number of rats per group.
*High Fat versus Low Fat Diet, P,0.01.
{
High Fat Normal Iron versus Low Fat Normal Iron and High Fat Iron Deficient, P,0.01.
doi:10.1371/journal.pone.0019739.t001

Results

Fatty acid oxidation by muscle
The capacity to oxidize fatty acids was evaluated by measuring
the rate of 14CO2 production from [14C] oleate by whole
homogenates of triceps muscle under conditions in which ADP
and Pi are not rate-limiting. In previous studies, it was found that
high fat diets induce an increase in the ability of skeletal muscle to
oxidize fatty acids [20–22], In the present study, the rate of oleate
oxidation by triceps muscles was 60% higher in the high fat,
normal iron, than in the low fat, normal iron control group
(Fig. 3A). However, this difference did not attain statistical
significance (P = 0.08) because of a large standard deviation.
Oleate oxidation was markedly reduced in muscle of the high fat
diet, iron deficient group (Fig. 3A). As shown in Fig. 3B, long chain
fatty acyl-CoA dehydrogenase (LCAD) protein expression, which
was used as a marker for the capacity of the b-oxidation pathway,
was increased about 2-fold in muscles from both the normal iron
and the iron-deficient high fat diet fed rats. Expression of the
enzymes of the fatty acid oxidation pathway is coordinately

Body weights
The high fat diets resulted in a significant increase in weight
gain (Table 1). Iron deficiency partly protected against the increase
in plasma insulin induced by feeding a high fat diet.

Muscle triglycerides
As in previous studies [18,19], the high fat diet resulted in
significant increases in muscle triglyceride concentration in the two
high fat diet groups (Fig. 1).

Muscle glucose transport
The high fat diet resulted in severe insulin resistance of muscle
glucose transport. As shown in Fig. 2, iron deficiency not only
completely protected against the high fat diet-induced muscle insulin
resistance, but also resulted in somewhat higher glucose transport rates
compared to muscles from rats on the normal iron-containing diets.

Figure 1. Triglyceride concentration in soleus muscles. Values are means 6 SE for 8 muscles per group. High fat diet groups versus control
diet group, P,0.01.
doi:10.1371/journal.pone.0019739.g001
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Figure 2. Maximally insulin stimulated (2 mU insulin/ml) glucose transport activity. 2-Deoxy-[3H] glucose uptake was measured in soleus
muscle strips in vitro. Values are means 6 SE for 8 muscles per group except for the low fat iron deficient diet groups, in which there were 4 muscles
per group. {High Fat diet, Normal Iron group versus Low Fat diet, Normal Iron group, P,0.01. #Insulin stimulated Iron-Deficient, High Fat diet group
versus Insulin-Stimulated Normal Iron, Low Fat diet group, P,0.05.
doi:10.1371/journal.pone.0019739.g002

of representative iron-containing proteins of the mitochondrial
respiratory chain. This effect was present in both the low fat
(Fig. 5A) and high fat (Fig. 5B) diet groups. Expression of the
glucose transporter GLUT4 in skeletal muscle, was unaffected by
iron deficiency (Fig. 5A and B). Similar effects of iron deficiency
were observed in triceps and gastrocnemius muscles (data not
shown).

regulated by PPARd and PPARa, transcription factors that are
activated by fatty acids, so LCAD can be used as a marker for the
capacity of the mitochondrial fatty acid oxidative enzyme pathway
[23].

PGC-1a response
Feeding rats a high fat diet induces an increase in PGC-1a
protein expression in muscle [21,22,24]. This increase in PGC-1a
occurs gradually over about a 4 wk period and is mediated by a
post transcriptional effect that appears to result from PPARd
activation [22]. As shown in Fig. 4, five weeks of high fat diet
feeding resulted in a significant increase in PGC-1a protein
expression in soleus muscle. The iron deficient diets resulted in an
unexpected, large decrease in PGC-1a protein. This finding came
as a surprise, as there is no obvious reason why iron deficiency
should affect PGC-1a protein level.

Ratios of LCAD to electron transport chain markers
To evaluate the magnitude of the imbalance between the fatty
acid oxidation and the ETC created by iron deficiency and a high
fat diet, we measured the enzyme activities of LCAD and the iron
containing, electron transport chain enzyme NADH dehydrogenase. As shown in Figure 6A, there was an increase in LCAD
activity and a large decrease in the activity of NADH
dehydrogenase in muscle of the iron deficient, high fat diet fed
rats. As a result, there was a more than 2-fold increase in the ratio
of LCAD activity, representative of the fatty acid oxidation
pathway, to NADH dehydrogenase, representative of the ETC
(Fig. 6B). A similar change occurred in the ratio of LCAD protein
to cytochrome c protein (Fig. 6D).

Mitochondrial proteins and GLUT4
It was previously found that severe iron deficiency, similar to
that induced in the present study, has no effect on the levels of
enzymes of the mitochondrial fatty acid oxidation pathway or on
non-iron containing enzymes of the citrate cycle [13]. The fatty
acid oxidation and citrate cycle enzymes measured included
carnitine palmitoyl transferase, 3-hydroxyacyl-CoA dehydrogenase, 3-ketoacid CoA thiolase, citrate synthase, isocitrate
dehydrogenase, and fumarase [13]. There were large decreases
in iron-containing compounds of the electron transport chain
[13].
In the present study the expression of citrate synthase, a noniron containing enzyme of the citrate cycle, was unaffected by the
iron deficiency in soleus muscle in both low-fat (Fig. 5A) and high
fat diet groups (Fig. 5B). As in previous studies [13,25], iron
deficiency resulted in a marked decrease in expression of a number
PLoS ONE | www.plosone.org

AMP-activated protein kinase (AMPK) phosphorylation
It seemed possible that, as in previous studies in which
mitochondrial dysfunction in muscle resulted in an increase in
glucose transport activity [26,27], there might be an increase in
AMPK activity in the iron-deficient muscles. This turned out to be
the case as evidenced by a significant increase in AMPK
phosphorylation in the iron-deficient muscles (Fig. 7). There was
no difference in AMPK phosphorylation between the irondeficient high fat diet and the iron-deficient chow diet groups, so
the data on these groups was combined under ‘‘iron-deficient
diet’’.
3
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which is low in resting muscle. Even patients with type 2 diabetes
with a low exercise capacity are able to increase the rate of fat
oxidation by muscle many fold in response to exercise. It,
therefore, seems improbable that a 30% decrease in muscle
mitochondria could limit fat oxidation in resting muscle.
Furthermore, a decrease in mitochondria severe enough to limit
fat oxidation would result in compensatory increase in glucose
uptake and utilization by muscle, not insulin resistance.
The finding that rats fed high fat diets develop insulin resistance
despite a concomitant increase in muscle mitochondria and in the
ability to oxidize fat [21,22] also argues against the concept that a
decrease in mitochondria mediates insulin resistance. Direct
evidence against the mitochondrial dysfunction causes insulin
resistance hypothesis is provided by the results of studies in rodents
showing that severe impairment of mitochondrial function in
muscle results in increased basal and insulin-stimulated muscle
glucose uptake [26–28]. Furthermore, Asian Indians with severe
insulin resistance and diabetes have an enhanced muscle
mitochondrial capacity for ATP production [29], and weight loss
induced by bilio-pancreatic diversion that results in reversal of
insulin resistance and type 2 diabetes is not associated with an
increase in muscle mitochondria [30]. The effect of impaired
mitochondrial function has also been studied in vitro by Brown
et al. [31], who incubated human muscle cell cultures with sodium
azide and found that a ,50% decrease in respiration increased
insulin independent glucose transport and had no effect on insulinstimulated glucose transport or Akt phosphorylation.
However, these arguments do not apply to a new version of the
mitochondrial deficiency hypothesis proposed by Ritov et al. [12].
These investigators found that muscle mitochondria of type 2
diabetic patients had a significantly reduced activity of NADH
oxidase and electron transport chain (ETC) activity but no
deficiency of citrate synthase or b-hydroxyacyl-CoA dehydrogenase activities. Based on these findings, Ritov, et al. [12]
hypothesized that ‘‘a deficiency of ETC and disbalance between
ETC and b-oxidation’’ causes insulin resistance due to accumulation of toxic byproducts of incomplete oxidation of fat.
The purpose of the present study was to test the hypothesis of
Ritov et al. [12] that insulin resistance is caused by a reduced
capacity of the mitochondrial electron transport chain relative to
the capacity of the fatty acid b-oxidation pathway. In our
experimental model, rats that were made severely iron deficient
and fed a high fat diet, the imbalance between the capacity for boxidation of fatty acids and the capacity of the electron transport
chain in muscle was considerably more severe than that reported
for human diabetic muscle by Ritov et al. [12]. Not only were the
levels of the ETC proteins cytochrome c and succinate ubiquinone
oxidoreductase markedly reduced, but LCAD, which we used as a
marker for the fatty acid b-oxidation pathway, was increased ,2fold in the high fat diet fed rats. Similar to these changes in
mitochondrial protein levels, the ratio of LCAD enzyme activity to
NADH dehydrogenase activity was ,2-fold higher in irondeficient than in control muscles. Expression of the enzymes of
the b-oxidation pathway is coordinately regulated by the nuclear
receptors PPARd and a which are activated by fatty acids, and
LCAD is, therefore, a marker for the response of the fatty acid
(FA) oxidation pathway [23]. Despite this large imbalance between
the capacities for fatty acid b-oxidation and the ETC, the iron
deficient muscles not only did not become insulin resistant, but
were completely protected against the insulin resistance induced
by a high fat diet. We think that the present results, together with
those of Wrendenberg et al. [27], disprove the concept that a
reduction in ETC capacity relative to the capacity of the fatty acid
b-oxidation pathway causes insulin resistance. It should also be

Figure 3. Oleate oxidation by triceps muscle homogenates.
A. The capacity to oxidize fatty acids was evaluated by measuring the
rate of CO2 production from [14C] oleate under conditions in which ADP
and Pi are not limiting. Bars are means 6 SE for 7 to 8 muscles per
group. *High Fat, Iron-Deficient diet versus other groups, P,0.05. B.
Long chain acyl-CoA dehydrogenase (LCAD) protein expression in
triceps muscle was measured by Western blot analysis. *High Fat diets
versus control Low Fat diet, P,0.01.
doi:10.1371/journal.pone.0019739.g003

Discussion
Patients with type 2 diabetes and obese, insulin resistant
individuals generally have 30% less mitochondria in their muscles
than normal age-matched individuals [2,4,5]. This finding led to
the hypothesis that a reduction in mitochondrial content of skeletal
muscle impairs the ability of muscle to oxidize fat, resulting in lipid
accumulation and insulin resistance [2,9]. There are a number of
arguments against this concept (reviewed in [11]. The rate of
substrate utilization is determined by the rate of ATP utilization,
PLoS ONE | www.plosone.org
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Figure 4. PGC-1a expression in soleus muscle was measured by Western blot analysis. Bars are means 6 SE for 5 to 7 muscles per group.
*High Fat diet versus Low Fat control diet group, P,0.01. {Iron deficient diet groups versus normal iron groups, P,0.01.
doi:10.1371/journal.pone.0019739.g004

noted that, in contrast to the report by Ritov et al. [12], a number
of other studies have found that the remaining mitochondria in
muscles of diabetic and insulin-resistant obese humans have
normal function [32,33], and that mitochondria of insulin resistant
[24,34] and diabetic [34] rodent muscles also have normal
function.
As in previous studies of the effects of mitochondrial dysfunction
[26,27], AMP kinase was activated in the iron deficient muscles.
AMPK activation results in an increase in glucose transport
activity in muscle that is additive to the effect of insulin [35–39].
This probably explains why glucose transport was higher in the
iron deficient than in the normal iron muscles.
A high fat diet or raising plasma FFA level induces an increase
in mitochondrial biogenesis [20–22] that is mediated by activation
of PPARd, which brings about a post translational increase in
PGC-1a protein [22]. Furthermore, PGC-1a is activated via
phosphorylation by AMPK [40], which would normally induce an
increase in GLUT4 [41–43]. We, therefore, expected that noniron containing mitochondrial proteins and GLUT4 would be
increased in the iron deficient muscles. However, this adaptation
was prevented by a large decrease in PGC-1a protein. This finding
came as a surprise, as we knew of no evidence that iron plays a role
in regulating PGC-1a expression. However, a literature search
turned up a paper by Ishii et al. [44] showing that prevention of
iron uptake by chelation of iron resulted in inhibition of PGC-1b
expression in osteoclasts, while treatment with transferrin
increased PGC-1b expression. Our finding of a marked reduction
in PGC-1a expression in iron deficient muscles provides evidence
that iron availability similarly regulates PGC-1a expression in
muscle, and explains why citrate synthase and GLUT4 expression
were not increased. It is interesting in the present context that
muscle specific PGC-1a knockout mice that were expected to be
insulin resistant because of a decrease in respiratory chain
PLoS ONE | www.plosone.org

proteins, were found to be considerably more insulin sensitive
than wild type mice as reflected in glucose uptake during a
hyperinsulinemic clamp [45].
In conclusion, the results of this study argue against the
hypothesis of Ritov et al. [12] that ‘‘a deficiency of electron
transport chain (ETC) and disbalance between ETC, b-oxidation
and TCA cycle’’ causes muscle insulin resistance, and provide
further evidence that mitochondrial deficiency/dysfunction does
not mediate muscle insulin resistance.

Methods
Animal Care
This work was approved by the Animal Studies Committee of
Washington University School of Medicine (Animal Welfare
Assurance #A-3381-01; Approval Number: 20090104). Male
Wistar rats weighing ,50 g were individually housed with a
12:12 hr light/dark cycle. The animals were given ad libitum
access to water and food.

Diets
The diets were obtained from Harlan Teklad (Madison, WI). The
iron deficient diets were made with low-iron casein and iron-deficient
mineral mix. The iron deficient low-fat diet contained ,4.0 kcal/g
with 11% of calories from fat. The iron-deficient high fat diet
contained ,5 kcal/g with 50% of calories provided by fat (43% lard,
7% soybean oil). The normal iron high fat diet had the same protein,
carbohydrate and fat content as the iron deficient high fat diet.

Study Design
The rats were assigned to two groups and fed either the iron
containing or the iron deficient low fat diets for nine weeks. Fifty
5
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Figure 5. Effects of iron deficiency on expression of citrate synthase and iron-containing mitochondrial respiratory chain proteins
in soleus muscles of A) Low Fat and B) High Fat diet groups. Bars are means 6 SE for 7 to 8 muscles per group. *Iron Deficient versus Normal
Iron, Low Fat control diet group, P,0.01.
doi:10.1371/journal.pone.0019739.g005

percent of the animals on the iron containing diet were then started
on the iron containing high fat diet, and fifty percent of the rats that
had been on the iron-deficient diet were started on the iron deficient
high fat diet. After five weeks on the high fat or low fat diets, the rats
were used for measurement of muscle glucose transport and
mitochondrial oxidative capacity and respiratory chain protein levels.
PLoS ONE | www.plosone.org

Treatment of animals
After an overnight fast that began at 1800 hr, rats were
anesthetized with sodium pentobarbital 50 mg/100 g body weight
between 10:00 am and 11:00 am. A week before the rats were
killed, blood was obtained from a tail vein between 10:00 am and
11:00 am for measurement of glucose and insulin. The soleus and
6
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Figure 6. Ratios of long chain acyl CoA dehydrogenase (LCAD) to NADH dehydrogenase (NADHDH) in soleus muscle. A. LCAD and
NADHDH enzyme activity levels. B. Ratio of LCAD activity to NADHD activity. C. LCAD and cytochrome c (Cyto c) protein levels. D. Ratios of LCAD to
Cyto c protein levels, *P,0.05.
doi:10.1371/journal.pone.0019739.g006

Irvine, CA) (0.2 mCi/ml) and 2 mU/ml insulin if it was present in
the previous incubations, to measure 2-DG transport rates [47].
The gas phase throughout was 95% O2-5% CO2. Intracellular 2DG accumulation and extracellular space were determined as
described previously [47,48].

triceps muscles were dissected out and used for measurement of
glucose transport (soleus) and oleate oxidation (triceps), and the
gastrocnemius muscle was clamp frozen in situ. Samples for future
analysis were stored at 280uC.

Measurement of glucose transport activity
Measurement of oleate oxidation

Soleus muscles were split longitudinally into strips to allow
adequate diffusion of oxygen and substrates [46]. One strip was
used for measurement of glucose transport activity and the
remaining portion of soleus muscle was frozen for later
measurement of mitochondrial proteins. The soleus muscle strips
were incubated with shaking at 30uC for 1 hr in 2.0 ml of
oxygenated Krebs-Henseleit buffer (KHB) supplemented with
8 mM glucose, 32 mM mannitol, and 0.1% bovine serum albumin
with or without 2 mU/ml insulin (a maximally effective concentration). Muscles were then washed for 10 min in KHB containing
40 mM mannitol, with or without 2 mU/ml insulin to remove
glucose from the extracellular space. Muscles were then incubated
for 20 min in 1.0 ml of KHB containing 4 mM 2-deoxy-[3H]
glucose (2DG) (American Radiolabeled Chemicals, St. Louis, MO)
(1.5 mCi/ml) and 36 mM [14C] mannitol (ICN Radiochemicals,
PLoS ONE | www.plosone.org

Triceps muscles were minced and homogenized in ice-cold
300 mM sucrose containing 10 mM TrisCl and 2 mM EDTA
using a Potter-Elveheim glass homogenizer to give a 5%
homogenate. Oleate-1-14C oxidation by whole homogenates was
measured as described previously for [14C] palmitate [20].

Measurement of muscle triglycerides
Muscle triglyceride concentration was determined by extracting
total lipids from clamp-frozen soleus muscle samples with
chloroform-methanol (2:1 vol.vol) as described by Folch et al
[49], separating the chloroform and methanol-water phases,
removing phospho-lipids, and further processing the sample using
Frayn and Maycock’s [50] modification of the method of Denton
and Randle [51]. Triglycerides were then quantified spectropho7
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Figure 7. AMP-kinase phosphorylation was measured by Western blot analysis. Each bar represents the mean 6 SE for 12 muscles per
group. *Iron Deficient versus Normal Iron control diet, P,0.01.
doi:10.1371/journal.pone.0019739.g007

tometrically as glycerol using an enzymatic assay kit (Sigma
Chemical).

Measurement of enzyme activities
Long chain Acyl-CoA dehydrogenase activity was measured as
described by Ijlst and Wanders [52]. NADH dehydrogenase
activity was measured using an enzyme activity microplate assay
kit (Mito Sciences, Eugene, OR).

Western blotting
Muscles were homogenized in ice-cold buffer containing
250 mM sucrose, 10 mM HEPES/1 mM EDTA (pH 7.4),
1 mM each of Pefabloc (Roche), EDTA, and NaF, 1 mg/ml of
aprotinin, leupeptin, and pepstatin, 0.1 mM bpV(phen), and
2 mg/ml b-glycerophosphate. Homogenates were subjected to
three freeze/thaw cycles and centrifuged for 10 min at 7006 g.
Protein concentration was determined using the Lowry Method.
Aliquots were solubilized in Laemmli buffer and subjected to
SDS/PAGE. The following antibodies were used for immunoblotting: succinate-ubiquinone oxidoreductase (SUO), cytochrome
oxidase subunit 1 (COX1), cytochrome oxidase subunit IV
(COXIV) (Molecular Probes), citrate synthase (CS) (Alpha
Diagnostic), cytochrome c (cyt c) (Phar-Mingen International),
long chain acyl-CoA dehydrogenase (LCAD) (a gift from Dan
Kelly), peroxisome proliferator-activated receptor d coactivator-1a
(PGC-1a), adenosine monophosphae kinase AMPK and phospho
AMPK (Cell Signaling, Beverly, MA) and GLUT4 (a gift from
Mike Mueckler). After incubation with the appropriate secondary
antibodies, bands were visualized by ECL and quantified by
densitometry.

Statistical analysis
Results are expressed as means 6 SE. The significance of
differences between two groups was assessed using Student’s t-test.
For multiple comparisons, significance was determined by oneway analysis of variance followed by a post hoc comparison using
Tukey significant difference method.
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